Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | SAUL analysis: atezolizumab in urothelial carcinoma patients

Cora Sternberg, MD, FACP, Weill Cornell Medicine, New York, NY, discusses the subgroup analysis of the single-arm international SAUL study (NCT02928406) in pretreated locally advanced urinary tract carcinoma. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.